# Nutrition in non-small cell lung cancer
Nutrition plays a supportive role in the treatment of non-small cell lung cancer. Research shows that the nutritional status and muscle composition of patients influence how they tolerate treatment and their outcomes. This tab describes which nutritional patterns and diets are being investigated or applied in this disease.
Protein-rich nutrition and muscle support
ResearchediPositive results in clinical studies, not yet standard treatment
Protein-rich nutrition is based on the assumption that adequate protein is consumed daily to maintain muscle and tissue quality. This is especially important for patients with lung cancer, because severe weight loss and muscle loss (sarcopenia) are common and can be worsened by the disease itself and by treatments such as chemotherapy, radiation, or surgery.
Recent research (2026) shows that patients with better preserved muscle mass respond better to immunotherapy and have fewer complications after surgery. Studies suggest that the 'prognostic nutritional index' — a measure that combines protein, weight, and inflammatory values — is associated with survival. Patients who eat better have less severe side effects from therapy and better chances of recovery after surgery.
An important fact: it is not just about calories, but especially about adequate protein in combination with physical activity. Muscle mass is a strong predictor of tolerance for treatment.
*Risks:* no direct risks known; however, it is important that protein supplementation is well-timed around chemotherapy or radiation days, as these days can cause gastrointestinal problems.
Immune-supporting nutrition (perioperative nutrition)
ResearchediPositive results in clinical studies, not yet standard treatment
Perioperative immune-supporting nutrition consists of nutritional ingredients (such as specific amino acids, omega-3 fatty acids, and certain vitamins) that are specially formulated to strengthen the immune system around the time of surgery. This is particularly investigated in patients who need to have a lung cancer tumor surgically removed.
Research from 2026 shows that patients who receive extra immune support perioperatively have fewer infections and complications after surgery and need shorter hospital stays. The principle is that the body can use extra 'nutritional weapons' around surgery to promote recovery.
This type of nutrition usually forms part of a comprehensive package around the procedure; general practitioners or hospital dietitians put this together.
*Risks:* no known risks; however, good communication with the treatment team is important so that timing aligns with the surgery.
Mediterranean dietary pattern
ResearchediPositive results in clinical studies, not yet standard treatment
The Mediterranean nutritional pattern focuses on plenty of vegetables, fruits, whole grains, fish, olive oil, and moderate amounts of meat. The pattern is anti-inflammatory in nature and contains many antioxidants.
For lung cancer, this pattern has been investigated in a few studies because lung cancer patients often experience inflammatory reactions that can accelerate the disease or complicate treatment. The pattern can help keep these inflammatory values lower, although direct evidence specific to lung cancer is still limited. It has been shown that patients with lower inflammatory values respond better to immunotherapy.
*Risks:* no known risks for cancer patients; a cautionary note: with certain immunotherapies, certain nutritional ingredients may have interactions (for example, certain supplements), so coordination with the team is advisable.
Ketogenic diet
ExperimentaliOngoing in study setting, outcome still unknown
The ketogenic diet severely restricts carbohydrates and increases fats and proteins, causing the body to enter ketosis (a metabolic state). Theoretically, this could hinder cancer cells because they are glucose-dependent. For lung cancer, no significant clinical trials have been completed to date.
A few preclinical studies suggest possible effects, but this is far from enough for a recommendation. Lung cancer patients already have a high risk of weight loss; a very restrictive diet could worsen this.
*Risks:* weight loss, possible impaired nutrient absorption, fatigue. Not recommended without strict guidance from your treatment team.
Nutrition for weight loss and nutritional needs
ResearchediPositive results in clinical studies, not yet standard treatment
Weight loss is a major problem for many lung cancer patients. This can result from the tumor itself (which consumes a lot of energy), from treatments (chemotherapy and radiation can severely affect appetite and the gastrointestinal system) and from side effects such as nausea and changes in taste perception.
Targeted nutritional management — with higher calorie and protein density, small divided meals, and adjustment to what the patient can eat — is well researched and part of standard treatment. Patients with better preserved weight and nutritional status recover faster from surgery, tolerate chemotherapy and immunotherapy better, and have better survival chances.
The 'Prognostic Nutritional Index' (PNI), a number that combines serum albumin (protein in blood), total lymphocyte count and other factors, proved in multiple 2026 studies to be a strong predictor of outcomes. Patients with higher PNI values do better.
*Risks:* none, but timing and adjustment to treatment moments is crucial; poorly timed nutrition can worsen side effects.
---
Nutritional choices and support strategy are tailored to the individual. They belong in treatment planning with your own doctor, lung specialist or specialized dietitian. They know your full situation — which treatment you receive, your taste changes, your gastrointestinal system — and can tailor accordingly. Many hospitals have dietitians who specialize in cancer nutrition.
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._